메뉴 건너뛰기
Journal of Neurology
Volumn 260, Issue 8, 2013, Pages 2052-2056
Immunoglobulin G level variations in treated chronic inflammatory demyelinating polyneuropathy: Clues for future treatment regimens?
Author keywords

Chronic inflammatory demyelinating polyneuropathy; Immunoglobulin G levels; Intravenous immunoglobulins
Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;
EID: 84881554935     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6938-7     Document Type: Article
Times cited : (37)
References (11)
  • 2
    • 73649096179 scopus 로고    scopus 로고
    • Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies
    • 10.2174/157015909790031166 1:CAS:528:DC%2BC3cXns12h
    • Jacob S, Rajabally YA (2009) Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Current Neuropharmacol 7:337-342
    • (2009) Current Neuropharmacol , vol.7 , pp. 337-342
    • Jacob, S.1    Rajabally, Y.A.2
  • 3
    • 33750896818 scopus 로고    scopus 로고
    • Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy
    • 17117941 10.1111/j.1529-8027.2006.00105.x 1:CAS:528: DC%2BD2sXhtFGluw%3D%3D
    • Rajabally YA, Seow H, Wilson P (2006) Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 11:325-329
    • (2006) J Peripher Nerv Syst , vol.11 , pp. 325-329
    • Rajabally, Y.A.1    Seow, H.2    Wilson, P.3
  • 4
    • 72949096337 scopus 로고    scopus 로고
    • Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome
    • 19938102 10.1002/ana.21737 1:CAS:528:DC%2BC3cXjslChtw%3D%3D
    • Kuitwaard K, de Gelder J, Tio-Gillen AP et al (2009) Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol 66:597-603
    • (2009) Ann Neurol , vol.66 , pp. 597-603
    • Kuitwaard, K.1    De Gelder, J.2    Tio-Gillen, A.P.3
  • 5
    • 79959619871 scopus 로고    scopus 로고
    • Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP
    • 21696496 10.1111/j.1529-8027.2011.00304.x
    • van Doorn PA, Kuitwaard K, Jacobs BC (2011) Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP. J Peripher Nerv Syst 16(3):38-40
    • (2011) J Peripher Nerv Syst , vol.16 , Issue.3 , pp. 38-40
    • Van Doorn, P.A.1    Kuitwaard, K.2    Jacobs, B.C.3
  • 6
    • 84879957059 scopus 로고    scopus 로고
    • Serum IgG levels in immunoglobulin treated chronic inflammatory demyelinating polyneuropathy
    • (Epub ahead of print)
    • Kuitwaard K, van Doorn PA, van den Berg LH, et al (2013) Serum IgG levels in immunoglobulin treated chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (Epub ahead of print)
    • (2013) J Neurol Neurosurg Psychiatry
    • Kuitwaard, K.1    Van Doorn, P.A.2    Van Den Berg, L.H.3
  • 7
    • 77649176429 scopus 로고    scopus 로고
    • European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society- First Revision
    • 20456730 10.1111/j.1468-1331.2009.02930.x
    • Van den Bergh PY, Hadden RD, Bouche P et al (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society- First Revision. Eur J Neurol 17:356-363
    • (2010) Eur J Neurol , vol.17 , pp. 356-363
    • Van Den Bergh, P.Y.1    Hadden, R.D.2    Bouche, P.3
  • 8
    • 0032918169 scopus 로고    scopus 로고
    • Chronic inflammatory demyelinating polyneuropathy: A prevalence study in south east England
    • 10209187 10.1136/jnnp.66.5.677 1:STN:280:DyaK1M3islamsg%3D%3D
    • Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK (1999) Chronic inflammatory demyelinating polyneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677-680
    • (1999) J Neurol Neurosurg Psychiatry , vol.66 , pp. 677-680
    • Lunn, M.P.1    Manji, H.2    Choudhary, P.P.3    Hughes, R.A.4    Thomas, P.K.5
  • 9
    • 65649085969 scopus 로고    scopus 로고
    • Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: Study of a UK population
    • 19260065 10.1002/mus.21206
    • Rajabally YA, Simpson BS, Beri S, Bankart J, Gosalakal J (2009) Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve 39:432-438
    • (2009) Muscle Nerve , vol.39 , pp. 432-438
    • Rajabally, Y.A.1    Simpson, B.S.2    Beri, S.3    Bankart, J.4    Gosalakal, J.5
  • 10
    • 2442531717 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in autoimmune neuromuscular diseases
    • 15150209 10.1001/jama.291.19.2367 1:CAS:528:DC%2BD2cXkt1Sjsbo%3D
    • Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367-2375
    • (2004) JAMA , vol.291 , pp. 2367-2375
    • Dalakas, M.C.1
  • 11
    • 79251572089 scopus 로고    scopus 로고
    • Raasch-built overall disabilty Scale (R-ODS) for immune mediated peripheral neuropathies
    • van Nes SI, Vanhoutte EK, van Doorn PA et al (2011) Raasch-built overall disabilty Scale (R-ODS) for immune mediated peripheral neuropathies. Neurology 67:337-345
    • (2011) Neurology , vol.67 , pp. 337-345
    • Van Nes, S.I.1    Vanhoutte, E.K.2    Van Doorn, P.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.